Tirzepatide KwikPen update: Practical guidance for clinicians

Description

In this Product Explainer, A/Prof Samantha Hocking, Endocrinologist, explains the key changes to the tirzepatide KwikPen device, including operational steps, dosing considerations and patient counselling, with practical guidance for supporting safe and effective use (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Terri-Lynne South

Dr Terri-Lynne South

Oral GLP1s – What GPs Need to Know

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Samantha Hocking

expert

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic, Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

Date published: 16 June 2026